Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
Open Access
- 1 December 2000
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (11) , 1425-1431
- https://doi.org/10.1054/bjoc.2000.1508
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Prognostic factors in colorectal cancerBritish Journal of Surgery, 1992
- Angiogenesis.1992
- Prognosis of node-positive colon cancerCancer, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Clinicopathological assessment and staging of colorectal cancerBritish Journal of Surgery, 1988
- Clinical perspective of human colorectal cancer metastasisCancer and Metastasis Reviews, 1984
- Recurrent colorectal carcinoma: detection, treatment, and other considerations.1971
- The natural history of carcinoma of the colon and rectumThe American Journal of Surgery, 1964